NCT03602586 2024-07-26Testing Whether the Combination of Two Immunotherapy Drugs Have Activity in Recurrent or Persistent Clear Cell Ovarian CancerNational Cancer Institute (NCI)Phase 2 Completed14 enrolled 12 charts
NCT01685255 2019-03-11A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line ChemotherapyIncyte CorporationPhase 2 Terminated83 enrolled